Palvella Therapeutics Inc.

XNAS:PVLA   4:00:00 PM EDT
113.99
-1.93 (-1.66%)
4:10:05 PM EDT: $113.99 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Palvella Therapeutics Inc. Stock, XNAS:PVLA

125 Strafford Avenue, Suite 360, Wayne, Pennsylvania 19087
United States of America
Phone: +1.484.253.1461
Number of Employees: 50
http://www.palvellatx.com

Description

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.